[go: up one dir, main page]

GB2162522B - An indole derivative - Google Patents

An indole derivative

Info

Publication number
GB2162522B
GB2162522B GB08519418A GB8519418A GB2162522B GB 2162522 B GB2162522 B GB 2162522B GB 08519418 A GB08519418 A GB 08519418A GB 8519418 A GB8519418 A GB 8519418A GB 2162522 B GB2162522 B GB 2162522B
Authority
GB
United Kingdom
Prior art keywords
indole derivative
indole
derivative
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB08519418A
Other versions
GB2162522A (en
GB8519418D0 (en
Inventor
Alexander William Oxford
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB848419575A external-priority patent/GB8419575D0/en
Priority claimed from GB848419550A external-priority patent/GB8419550D0/en
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Priority to GB08519418A priority Critical patent/GB2162522B/en
Publication of GB8519418D0 publication Critical patent/GB8519418D0/en
Publication of GB2162522A publication Critical patent/GB2162522A/en
Priority to MYPI87002751A priority patent/MY102564A/en
Application granted granted Critical
Publication of GB2162522B publication Critical patent/GB2162522B/en
Priority to CY1475A priority patent/CY1475A/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D209/24—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with an alkyl or cycloalkyl radical attached to the ring nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/08—Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/12—Radicals substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/14—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/14—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
    • C07D209/16—Tryptamines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Indole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GB08519418A 1984-08-01 1985-08-01 An indole derivative Expired GB2162522B (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
GB08519418A GB2162522B (en) 1984-08-01 1985-08-01 An indole derivative
MYPI87002751A MY102564A (en) 1984-08-01 1987-10-01 An indole derivative
CY1475A CY1475A (en) 1984-08-01 1989-07-21 An indole derivative

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB848419575A GB8419575D0 (en) 1984-08-01 1984-08-01 Chemical compounds
GB848419550A GB8419550D0 (en) 1984-08-01 1984-08-01 Automobile invalid seat
GB08519418A GB2162522B (en) 1984-08-01 1985-08-01 An indole derivative

Publications (3)

Publication Number Publication Date
GB8519418D0 GB8519418D0 (en) 1985-09-04
GB2162522A GB2162522A (en) 1986-02-05
GB2162522B true GB2162522B (en) 1988-02-24

Family

ID=27262427

Family Applications (1)

Application Number Title Priority Date Filing Date
GB08519418A Expired GB2162522B (en) 1984-08-01 1985-08-01 An indole derivative

Country Status (2)

Country Link
CY (1) CY1475A (en)
GB (1) GB2162522B (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2108328C1 (en) * 1990-12-12 1998-04-10 Глэксо Груп Лимитед 3-[2-(dimethylamino)-ethyl]-n-methyl-1h-indole-5-methane sulfoneamide sulfate salt (2:1) or its pharmaceutically acceptable solvates, method of their synthesis, pharmaceutical compositions based on thereof, method of headache treatment
RU2108326C1 (en) * 1993-02-26 1998-04-10 Вита-Инвест С.А. Method of synthesis of 2-carboxy-3-[2-(dimethylamino)-ethyl]- -n-methyl-1h-indole-5-methane sulfoneamide
US10603305B2 (en) 2009-09-25 2020-03-31 Upsher-Smith Laboratories, Llc Formulations comprising triptan compounds
US11337962B2 (en) 2009-09-25 2022-05-24 Upsher-Smith Laboratories, Llc Formulations comprising triptan compounds

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8601959D0 (en) * 1986-01-28 1986-03-05 Glaxo Group Ltd Indole derivatives
GB8719167D0 (en) * 1987-08-13 1987-09-23 Glaxo Group Ltd Chemical compounds
KR0131327B1 (en) * 1987-08-13 1998-04-17 Glaxo Group Ltd Indole derivatives
US5225431A (en) * 1987-10-23 1993-07-06 Burroughs Wellcome Co. Therapeutic substituted indole compounds and compositions thereof
GB8928208D0 (en) * 1989-12-13 1990-02-14 Glaxo Group Ltd Medicaments
US5155218A (en) 1990-05-08 1992-10-13 Neurogenetic Corporation Dna encoding human 5-ht1d receptors
US5935925A (en) * 1990-05-08 1999-08-10 Synaptic Pharmaceutical Corporation Methods of treating migraine and compounds useful for such methods
GB9013845D0 (en) * 1990-06-21 1990-08-15 Glaxo Group Ltd Process
US5077293A (en) * 1990-06-29 1991-12-31 Bristol-Myers Squibb Co. 1-indolyalkyl-4-(alkoxypyrimidinyl)piperazines
CA2043709C (en) * 1990-06-29 2002-01-22 David W. Smith Antimigraine alkoxypyrimidine derivatives
GB9022250D0 (en) * 1990-10-12 1990-11-28 Glaxo Group Ltd Medicaments
GB9027827D0 (en) * 1990-12-21 1991-02-13 Glaxo Laboratoires Pharmaceutical compositions
US5468504A (en) * 1990-12-21 1995-11-21 Laboratoires Glaxo S.A. Effervescent pharmaceutical compositions
GB9103770D0 (en) * 1991-02-22 1991-04-10 Glaxo Group Ltd Chemical compounds
GB9104890D0 (en) * 1991-03-08 1991-04-24 Glaxo Group Ltd Compositions
CA2084531A1 (en) * 1991-12-19 1993-06-20 David W. Smith Antimigraine 4-pyrimidinyl and pyridinyl derivatives of indol-3yl-alkyl piperazines
GB9201038D0 (en) * 1992-01-16 1992-03-11 Glaxo Group Ltd Chemical compounds
FR2686339B1 (en) * 1992-01-22 1994-03-11 Adir Cie NOVEL NAPHTHALENIC AMIDES AND SULFONAMIDES, PROCESSES FOR THEIR PREPARATION AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
GB9209882D0 (en) * 1992-05-07 1992-06-24 Glaxo Lab Sa Compositions
GB9211276D0 (en) * 1992-05-28 1992-07-15 Glaxo Lab Sa Pharmaceutical compositions
GB9211277D0 (en) 1992-05-28 1992-07-15 Glaxo Group Inc Pharmaceutical compositions
EP0574624B1 (en) * 1992-06-17 1997-09-10 Laboratoires Glaxo Sa Pharmaceutical compositions
ES2059236B1 (en) * 1992-06-18 1995-06-16 Imidex S A PROCEDURE FOR THE SYNTHESIS OF 3- (2-DIMETILAMINO) ETIL) -N-METHYL-1H-INDOL-5-METHANOSULFONAMIDE.
ES2055651B1 (en) * 1992-07-20 1995-03-01 Vita Invest Sa PROCEDURE FOR THE OBTAINING OF NEW AMIDINES DERIVED FROM 3-AMINOETILINDOLES.
DE4314976C1 (en) * 1993-05-06 1994-10-06 Lohmann Therapie Syst Lts Transdermal therapeutic systems for the administration of drugs, process for their production and their use
US5382592A (en) * 1993-09-16 1995-01-17 Bristol-Myers Squibb Company Antimigraine cyclobutenedione derivatives of tryptamines
US5468768A (en) * 1994-01-06 1995-11-21 Bristol-Myers Squibb Company Antimigraine derivatives of indolylcycloalkanylamines
US5618816A (en) * 1995-03-02 1997-04-08 Bristol-Myers Squibb Company Antimigraine 1,2,5-thiadiazole derivatives of indolylalkyl-pyridnyl and pyrimidinylpiperazines
WO1997033579A1 (en) * 1996-03-13 1997-09-18 Glaxo Group Limited Medicaments comprising 5ht1-like receptor agonists with an increased absorption
FR2749846B1 (en) * 1996-06-17 1998-09-11 Pf Medicament METHANESULFONATE SALT OF ARYLPIPERAZINE DERIVED FROM TRYPTAMINE AND ITS SOLVATES FOR PHARMACEUTICAL USE
US6586458B1 (en) 1996-08-16 2003-07-01 Pozen Inc. Methods of treating headaches using 5-HT agonists in combination with long-acting NSAIDs
US5872145A (en) * 1996-08-16 1999-02-16 Pozen, Inc. Formulation of 5-HT agonist and NSAID for treatment of migraine
US8022095B2 (en) 1996-08-16 2011-09-20 Pozen, Inc. Methods of treating headaches using 5-HT agonists in combination with long-acting NSAIDs
US7189753B1 (en) 1997-11-06 2007-03-13 Cady Roger K Preemptive prophylaxis of migraine
GB9926250D0 (en) * 1999-11-06 2000-01-12 Knoll Ag Chemical process
AU2003243605A1 (en) * 2002-06-13 2003-12-31 Dr. Reddy's Laboratories Limited 3-'2-(dimethylamino) ethyl!-n-methyl-1h-indole-5-methanesulfonamide and the succinate thereof
WO2004060355A1 (en) 2002-12-26 2004-07-22 Pozen Inc. Multilayer Dosage Forms Containing NSAIDs and Triptans
WO2004076403A1 (en) * 2003-02-24 2004-09-10 Transform Pharmaceuticals, Inc. Sumatriptan crystalline forms, pharmaceutical compositions and methods
WO2004099140A1 (en) * 2003-05-08 2004-11-18 Hetero Drugs Limited Novel crystalline forms of sumatriptan succinate
GB2448183A (en) 2007-04-05 2008-10-08 Optinose As Nasal powder delivery device
BRPI0912038A2 (en) 2008-05-27 2017-06-20 Biota Scient Management Pty Ltd compound, mixture, pharmaceutical composition, use of the compound, and methods for treating and preventing picornavirus infection, and for forming the compound
RU2710372C2 (en) * 2009-09-25 2019-12-26 Д-Р Редди'С Лабораторис Лтд. Compositions containing triptane compounds
CA3010568C (en) 2016-01-27 2023-10-17 Instar Technologies A.S. Oromucosal nanofiber carriers for therapeutic treatment

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2108328C1 (en) * 1990-12-12 1998-04-10 Глэксо Груп Лимитед 3-[2-(dimethylamino)-ethyl]-n-methyl-1h-indole-5-methane sulfoneamide sulfate salt (2:1) or its pharmaceutically acceptable solvates, method of their synthesis, pharmaceutical compositions based on thereof, method of headache treatment
RU2108326C1 (en) * 1993-02-26 1998-04-10 Вита-Инвест С.А. Method of synthesis of 2-carboxy-3-[2-(dimethylamino)-ethyl]- -n-methyl-1h-indole-5-methane sulfoneamide
US10603305B2 (en) 2009-09-25 2020-03-31 Upsher-Smith Laboratories, Llc Formulations comprising triptan compounds
US11337962B2 (en) 2009-09-25 2022-05-24 Upsher-Smith Laboratories, Llc Formulations comprising triptan compounds
US12090139B2 (en) 2009-09-25 2024-09-17 Tonix Medicines, Inc. Formulations comprising triptan compounds

Also Published As

Publication number Publication date
GB2162522A (en) 1986-02-05
GB8519418D0 (en) 1985-09-04
CY1475A (en) 1989-07-21

Similar Documents

Publication Publication Date Title
EG17283A (en) An indole derivative
GB2162522B (en) An indole derivative
SG65790G (en) Indole derivatives
JPS6479152A (en) Heterocyclic derivative
GB2168973B (en) Indole derivatives
GB8602394D0 (en) Phenylisopropylamine derivative
GB2168347B (en) Indoles
IL76854A (en) Oxindole derivatives
ZA854355B (en) Indole derivatives
GB8506770D0 (en) Thiocyanopyrimidine derivative
ZA843375B (en) Indoline derivatives
SG4189G (en) An indole derivative
ZA858408B (en) Substituted azolylmethyl-cyclopropyl-carbinol derivatives
GB8420969D0 (en) Tetrahydro-beta-carboline derivative
ZA859244B (en) Indole derivatives
IE843130L (en) Indole derivatives
IE843062L (en) Indole derivatives
NZ224082A (en) Substituted indole derivatives
GB8423551D0 (en) Tetrahydro-beta-carboline derivative
GB8416719D0 (en) Tetrahydro-beta-carboline derivative
IE842075L (en) Indoles
IE840135L (en) Indoles
IE840002L (en) Tetrahydrocarbazole derivatives
GB8423384D0 (en) 2-isopropylaminopyrimidine derivative
IE56514B1 (en) Dibenzothiepin derivative

Legal Events

Date Code Title Description
CTFF Supplementary protection certificate filed

Free format text: SPC/GB93/071, 930617

CTFA Application for supplementary protection certificate granted

Free format text: SPC/GB93/071, 931005, EXPIRES:20060515

CTFE Supplementary protection certificate entered into force

Free format text: SPC/GB93/071: 20050801, EXPIRES: 20060515

Spc suppl protection certif: SPC/GB93/071

Filing date: 20050801

Expiry date: 20060515

PE20 Patent expired after termination of 20 years

Effective date: 20050731

SPCE Supplementary protection certificate expired

Free format text: SPC/GB93/071:, EXPIRES: 20060515

Spc suppl protection certif: SPC/GB93/071

Expiry date: 20060515